Alvotech Files March 2024 Report (6-K)
Ticker: ALVOW · Form: 6-K · Filed: Mar 20, 2024 · CIK: 1898416
| Field | Detail |
|---|---|
| Company | Alvotech (ALVOW) |
| Form Type | 6-K |
| Filed Date | Mar 20, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, 6-K, SEC
TL;DR
Alvotech filed its March 6-K, confirming 20-F annual report filings.
AI Summary
Alvotech filed a Form 6-K on March 20, 2024, to report its activities for the month of March 2024. The company, incorporated in Luxembourg, operates in the biological products sector and is subject to SEC file number 001-41421. This filing is made under the 1934 Act and indicates Alvotech will file its annual reports under Form 20-F.
Why It Matters
This filing provides an update on Alvotech's regulatory reporting status and confirms its adherence to SEC requirements for foreign private issuers.
Risk Assessment
Risk Level: low — This is a routine regulatory filing and does not contain new financial or operational information that would typically impact risk.
Key Players & Entities
- Alvotech (company) — Registrant
- 001-41421 (dollar_amount) — SEC File Number
- 20240320 (date) — Filing Date
- March 2024 (date) — Reporting Period
- Form 20-F (company) — Annual Report Form
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose is to report on Alvotech's activities for the month of March 2024 as a foreign private issuer.
What is Alvotech's SEC file number?
Alvotech's SEC file number is 001-41421.
Which form does Alvotech use for its annual reports?
Alvotech indicates it files its annual reports under cover of Form 20-F.
Where is Alvotech's principal executive office located?
Alvotech's principal executive office is located at 9, Rue de Bitbourg, L-1273 Luxembourg, Grand Duchy of Luxembourg.
What is Alvotech's Standard Industrial Classification code?
Alvotech's Standard Industrial Classification code is 2836, for Biological Products (No Diagnostic Substances).
Filing Stats: 387 words · 2 min read · ~1 pages · Grade level 10.6 · Accepted 2024-03-20 16:30:42
Filing Documents
- f6k_032024.htm (6-K) — 8KB
- exh_991.htm (EX-99.1) — 73KB
- exh_992.htm (EX-99.2) — 47KB
- exh_993.htm (EX-99.3) — 72KB
- 0001171843-24-001500.txt ( ) — 201KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Alvotech (Registrant) Date: March 20, 2024 /s/ Tanya Zharov Tanya Zharov General Counsel